Thank you for inquiring about the Preventive Care and Screening: Screening for Depression and Follow-Up Plan eCQM. The measure’s Guidance section indicates the following: “This measure does not require documentation of a specific score, just whether results of the normalized and validated depression screening tool used are considered positive or negative. Each standardized screening tool provides guidance on whether a particular score is considered positive for depression…” “Screening Tools: - An age-appropriate, standardized, and validated depression screening tool must be used for numerator compliance. - The name of the age-appropriate standardized depression screening tool utilized must be documented in the medical record.” 1. While your aggregation process may not receive information beyond the code, confirm with the specific provider sites whether the depression screening tools are named within the medical records. If they are named (and are age-appropriate, standardized and validated screening tools), per measure guidance, you may map the CPT and HCPCS codes that explicitly indicate positive or negative depression (3352F , G8431, G8510, G8511) to the appropriate code within the eCQM. · SNOMEDCT Code 428171000124102: Depression screening negative (finding) · SNOMEDCT Code 428181000124104: Depression screening positive (finding) 2. Non-specific codes that only indicate a depression screening was completed and without results would not be mapped to one of the SNOMED-CT codes above and would fail to meet the numerator criteria. The same would be true for those screened positive or negative, but with no mention of the depression screening tool used.

As a data aggregator supporting eCQM reporting, we often receive only CPT or HCPCS codes (e.g., 3352F, G8431, G8510, G8511) to represent completed depression screenings for CMS2v14. These codes lack accompanying clinical detail, such as screening results or standardized terminology like LOINC or SNOMED. Without a reliable method to translate these billing codes into recognized clinical codes, we risk underreporting or misrepresenting screenings—directly affecting measure performance, data accuracy, and compliance. Additionally, codes like 1220F, G0444, and 3725F signal screenings occurred, but it's unclear if they can be mapped to LOINC to meet structured data requirements. Resolving this translation gap is critical for ensuring accurate quality reporting and minimizing false gaps in care.